KOENIG SHELDON L. (Chief Operating Officer) sold 2.5% of their position (53.59K shares) of ESPERION THERAPEUTICS, INC. on the open market
Open‑market sale worth $169.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/18/2026ACC: 0001628280-26-044266
Officer· Chief Operating Officer
Since Dec 2020
-53.59K
Net shares
Net seller
$169.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
53.59K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−53.59K
Price / share
$3.15
Trade value
$169.07K
% of position
2.5%
6/17/2026
2.17M→2.12M
Total
Net shares
−53.59K
Net value
-$169.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/17/2026 | S · Sale | −53.59K | $3.15 | $169.07K | 2.5% | 2.17M | 2.12M |
| Total | −53.59K | -$169.07K | ||||||
Derivative Transactions0
No derivative transactions reported